Fu W, Hou X, Ding L, Wei J, Hou W
Front Cell Dev Biol. 2025; 13:1536320.
PMID: 40061015
PMC: 11885286.
DOI: 10.3389/fcell.2025.1536320.
Cerina V, Rui C, Di Cristofori A, Ferlito D, Carrabba G, Giussani C
Sci Rep. 2025; 15(1):2160.
PMID: 39820086
PMC: 11739379.
DOI: 10.1038/s41598-025-85400-9.
Fang Z, Shu T, Luo P, Shao Y, Lin L, Tu Z
Front Oncol. 2024; 14:1417208.
PMID: 39534094
PMC: 11554619.
DOI: 10.3389/fonc.2024.1417208.
Arlt F, Basaran A, Vogel M, Vychopen M, Seidel C, Barrantes-Freer A
Front Oncol. 2024; 14:1379692.
PMID: 38715788
PMC: 11074443.
DOI: 10.3389/fonc.2024.1379692.
Cui L, Qin Z, Sun S, Feng W, Hou M, Yu D
J Cancer Res Clin Oncol. 2024; 150(3):132.
PMID: 38492096
PMC: 10944436.
DOI: 10.1007/s00432-024-05642-4.
Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth model.
Metz M, Ezhov I, Peeken J, Buchner J, Lipkova J, Kofler F
Neurooncol Adv. 2024; 6(1):vdad171.
PMID: 38435962
PMC: 10907005.
DOI: 10.1093/noajnl/vdad171.
Unlocking Bevacizumab's Potential: rCBV as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients.
Alvarez-Torres M, Balana C, Fuster-Garcia E, Puig J, Garcia-Gomez J
Cancers (Basel). 2024; 16(1).
PMID: 38201588
PMC: 10778147.
DOI: 10.3390/cancers16010161.
Radiomics in the diagnosis of glioblastoma.
Kwiatkowska-Miernik A, Mruk B, Sklinda K, Zaczynski A, Walecki J
Pol J Radiol. 2023; 88:e461-e466.
PMID: 38020501
PMC: 10660137.
DOI: 10.5114/pjr.2023.132168.
Stereotactic Radiosurgery for Contrast-Enhancing Satellite Nodules in Recurrent Glioblastoma: A Rare Case Series From a Single Institution.
Park D, Persad A, Yoo K, Marianayagam N, Yener U, Tayag A
Cureus. 2023; 15(8):e44455.
PMID: 37664337
PMC: 10470661.
DOI: 10.7759/cureus.44455.
Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study.
Hao Y, Tang T, Ren J, Li G
Radiol Med. 2023; 128(10):1271-1283.
PMID: 37648956
DOI: 10.1007/s11547-023-01698-3.
Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
Han Q, Lu Y, Wang D, Li X, Ruan Z, Mei N
Eur Radiol. 2023; 33(12):9139-9151.
PMID: 37495706
DOI: 10.1007/s00330-023-09924-2.
Tumor-related epilepsy and post-surgical outcomes: tertiary hospital experience in Vietnam.
Le V, Nguyen A, Pham T, Nguyen P
Sci Rep. 2023; 13(1):10859.
PMID: 37407622
PMC: 10322847.
DOI: 10.1038/s41598-023-38049-1.
Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor.
Scola E, Del Vecchio G, Busto G, Bianchi A, Desideri I, Gadda D
Cancers (Basel). 2023; 15(11).
PMID: 37296953
PMC: 10252005.
DOI: 10.3390/cancers15112992.
The combination of radiomics features and VASARI standard to predict glioma grade.
You W, Mao Y, Jiao X, Wang D, Liu J, Lei P
Front Oncol. 2023; 13:1083216.
PMID: 37035137
PMC: 10073533.
DOI: 10.3389/fonc.2023.1083216.
The emerging potential of quantitative MRI biomarkers for the early prediction of brain metastasis response after stereotactic radiosurgery: a scoping review.
Hu J, Xie X, Zhou W, Hu X, Sun X
Quant Imaging Med Surg. 2023; 13(2):1174-1189.
PMID: 36819250
PMC: 9929394.
DOI: 10.21037/qims-22-412.
PIEZO1-Related Physiological and Pathological Processes in CNS: Focus on the Gliomas.
Hong R, Yang D, Jing Y, Chen S, Tian H, Yang Y
Cancers (Basel). 2023; 15(3).
PMID: 36765838
PMC: 9913778.
DOI: 10.3390/cancers15030883.
Observation of the delineation of the target volume of radiotherapy in adult-type diffuse gliomas after temozolomide-based chemoradiotherapy: analysis of recurrence patterns and predictive factors.
Liu H, Zhang L, Tan Y, Jiang Y, Lu H
Radiat Oncol. 2023; 18(1):16.
PMID: 36691100
PMC: 9872393.
DOI: 10.1186/s13014-023-02203-w.
MRI radiomic features of peritumoral edema may predict the recurrence sites of glioblastoma multiforme.
Long H, Zhang P, Bi Y, Yang C, Wu M, He D
Front Oncol. 2023; 12:1042498.
PMID: 36686829
PMC: 9845721.
DOI: 10.3389/fonc.2022.1042498.
Factors Involved in Preoperative Edema in High-Grade Gliomas.
Saito T, Mizumoto M, Liang H, Nakai K, Sumiya T, Iizumi T
Cureus. 2022; 14(11):e31379.
PMID: 36514578
PMC: 9741940.
DOI: 10.7759/cureus.31379.
The peritumoral brain zone in glioblastoma: where we are and where we are going.
Giambra M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera V, Basso G
J Neurosci Res. 2022; 101(2):199-216.
PMID: 36300592
PMC: 10091804.
DOI: 10.1002/jnr.25134.